Mag-aso, Edsel S.

HRN: 19-68-13  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/14/2022
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
06/14/2022
06/21/2022
IVTT
2.25g
Q8h
Liver Infection
Waiting Final Action 

 Indication:  Empiric    Type of Infection:  Intra-abdominal    Compliance to guidelines: Compliant To Guidelines

 Final appropriateness: Yes     

 Overall appropriateness: Yes